Search by Drug Name or NDC

    NDC 13668-0090-90 OLANZAPINE 20 mg/1 Details

    OLANZAPINE 20 mg/1

    OLANZAPINE is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is OLANZAPINE.

    Product Information

    NDC 13668-0090
    Product ID 13668-090_ef53caaf-ca68-a0fc-e053-2a95a90ace16
    Associated GPIs 59157060007240
    GCN Sequence Number 047286
    GCN Sequence Number Description olanzapine TAB RAPDIS 20 MG ORAL
    HIC3 H7T
    HIC3 Description ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST
    GCN 34023
    HICL Sequence Number 011814
    HICL Sequence Number Description OLANZAPINE
    Brand/Generic Generic
    Proprietary Name OLANZAPINE
    Proprietary Name Suffix n/a
    Non-Proprietary Name OLANZAPINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, ORALLY DISINTEGRATING
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name OLANZAPINE
    Labeler Name Torrent Pharmaceuticals Limited
    Pharmaceutical Class Atypical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091415
    Listing Certified Through 2024-12-31

    Package

    NDC 13668-0090-90 (13668009090)

    NDC Package Code 13668-090-90
    Billing NDC 13668009090
    Package 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-090-90)
    Marketing Start Date 2011-10-25
    NDC Exclude Flag N
    Pricing Information N/A